Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition.

Ballinger E, Mosior J, Hartman T, Burns-Huang K, Gold B, Morris R, Goullieux L, Blanc I, Vaubourgeix J, Lagrange S, Fraisse L, Sans S, Couturier C, Bacqué E, Rhee K, Scarry SM, Aubé J, Yang G, Ouerfelli O, Schnappinger D, Ioerger TR, Engelhart CA, McConnell JA, McAulay K, Fay A, Roubert C, Sacchettini J, Nathan C.

Science. 2019 Feb 1;363(6426). pii: eaau8959. doi: 10.1126/science.aau8959. Erratum in: Science. 2019 Jun 21;364(6446):.

2.

Expression of the human antimicrobial peptide β-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.

Bonamy C, Sechet E, Amiot A, Alam A, Mourez M, Fraisse L, Sansonetti PJ, Sperandio B.

Sci Rep. 2018 Dec 21;8(1):18043. doi: 10.1038/s41598-018-36387-z.

3.

High Accumulation and In Vivo Recycling of the New Antimalarial Albitiazolium Lead to Rapid Parasite Death.

Wein S, Taudon N, Maynadier M, Tran Van Ba C, Margout D, Bordat Y, Fraisse L, Wengelnik K, Cerdan R, Bressolle-Gomeni F, Vial HJ.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00352-17. doi: 10.1128/AAC.00352-17. Print 2017 Aug.

4.

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins.

Kling A, Lukat P, Almeida DV, Bauer A, Fontaine E, Sordello S, Zaburannyi N, Herrmann J, Wenzel SC, König C, Ammerman NC, Barrio MB, Borchers K, Bordon-Pallier F, Brönstrup M, Courtemanche G, Gerlitz M, Geslin M, Hammann P, Heinz DW, Hoffmann H, Klieber S, Kohlmann M, Kurz M, Lair C, Matter H, Nuermberger E, Tyagi S, Fraisse L, Grosset JH, Lagrange S, Müller R.

Science. 2015 Jun 5;348(6239):1106-12. doi: 10.1126/science.aaa4690.

PMID:
26045430
5.

A chemical proteomics approach for the search of pharmacological targets of the antimalarial clinical candidate albitiazolium in Plasmodium falciparum using photocrosslinking and click chemistry.

Penarete-Vargas DM, Boisson A, Urbach S, Chantelauze H, Peyrottes S, Fraisse L, Vial HJ.

PLoS One. 2014 Dec 3;9(12):e113918. doi: 10.1371/journal.pone.0113918. eCollection 2014.

6.

New insight into the mechanism of accumulation and intraerythrocytic compartmentation of albitiazolium, a new type of antimalarial.

Wein S, Tran Van Ba C, Maynadier M, Bordat Y, Perez J, Peyrottes S, Fraisse L, Vial HJ.

Antimicrob Agents Chemother. 2014 Sep;58(9):5519-27. doi: 10.1128/AAC.00040-14. Epub 2014 Jul 7.

7.

Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate.

Wein S, Maynadier M, Bordat Y, Perez J, Maheshwari S, Bette-Bobillo P, Tran Van Ba C, Penarete-Vargas D, Fraisse L, Cerdan R, Vial H.

Br J Pharmacol. 2012 Aug;166(8):2263-76. doi: 10.1111/j.1476-5381.2012.01966.x.

8.

The antimalarial ferroquine: from bench to clinic.

Biot C, Nosten F, Fraisse L, Ter-Minassian D, Khalife J, Dive D.

Parasite. 2011 Aug;18(3):207-14. Review.

9.

Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Xiong YQ, Hady WA, Deslandes A, Rey A, Fraisse L, Kristensen HH, Yeaman MR, Bayer AS.

Antimicrob Agents Chemother. 2011 Nov;55(11):5325-30. doi: 10.1128/AAC.00453-11. Epub 2011 Aug 22.

10.

Reliability of antimalarial sensitivity tests depends on drug mechanisms of action.

Wein S, Maynadier M, Tran Van Ba C, Cerdan R, Peyrottes S, Fraisse L, Vial H.

J Clin Microbiol. 2010 May;48(5):1651-60. doi: 10.1128/JCM.02250-09. Epub 2010 Mar 10.

11.

Selection of a trioxaquine as an antimalarial drug candidate.

Coslédan F, Fraisse L, Pellet A, Guillou F, Mordmüller B, Kremsner PG, Moreno A, Mazier D, Maffrand JP, Meunier B.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17579-84. doi: 10.1073/pnas.0804338105. Epub 2008 Nov 5.

12.

In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.

Henry M, Briolant S, Fontaine A, Mosnier J, Baret E, Amalvict R, Fusaï T, Fraisse L, Rogier C, Pradines B.

Antimicrob Agents Chemother. 2008 Aug;52(8):2755-9. doi: 10.1128/AAC.00060-08. Epub 2008 May 27.

13.

Probing the role of the covalent linkage of ferrocene into a chloroquine template.

Biot C, Daher W, Ndiaye CM, Melnyk P, Pradines B, Chavain N, Pellet A, Fraisse L, Pelinski L, Jarry C, Brocard J, Khalife J, Forfar-Bares I, Dive D.

J Med Chem. 2006 Jul 27;49(15):4707-14.

PMID:
16854077
14.

Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.

Daher W, Biot C, Fandeur T, Jouin H, Pelinski L, Viscogliosi E, Fraisse L, Pradines B, Brocard J, Khalife J, Dive D.

Malar J. 2006 Feb 7;5:11.

15.

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.

Daher W, Pelinski L, Klieber S, Sadoun F, Meunier V, Bourrié M, Biot C, Guillou F, Fabre G, Brocard J, Fraisse L, Maffrand JP, Khalife J, Dive D.

Drug Metab Dispos. 2006 Apr;34(4):667-82. Epub 2006 Jan 13.

PMID:
16415117
16.

Analysis of immune response patterns in naïve and Plasmodium berghei-infected young rats following a ferroquine treatment.

Pierrot C, Lafitte S, Dive D, Fraisse L, Brocard J, Khalife J.

Int J Parasitol. 2005 Dec;35(14):1601-10. Epub 2005 Aug 24.

PMID:
16140302
17.

A colorimetric 96-well microtiter plate assay for the determination of urate oxidase activity and its kinetic parameters.

Fraisse L, Bonnet MC, de Farcy JP, Agut C, Dersigny D, Bayol A.

Anal Biochem. 2002 Oct 15;309(2):173-9.

PMID:
12413448
18.

Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous.

Deguine V, Menasche M, Ferrari P, Fraisse L, Pouliquen Y, Robert L.

Int J Biol Macromol. 1998 Feb;22(1):17-22.

PMID:
9513812
19.

Determination of extracellular matrix degradation by free radicals using viscosity measurement of hyaluronan.

Deguine V, Menasche M, Fraisse L, Ferrari P, Pouliquen Y, Robert L.

Clin Chim Acta. 1997 Jun 27;262(1-2):147-52. No abstract available.

PMID:
9204217
20.

Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.

Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE, et al.

J Lipid Mediat. 1993 Aug;8(1):31-51.

PMID:
8257776
21.

The organo-specific external NADH dehydrogenase of mammal heart mitochondria has an artefactual origin.

Fraisse L, Rey E, Rigoulet M.

Biochim Biophys Acta. 1993 Jul 5;1143(2):190-8.

PMID:
8391314
22.

Long-chain-substituted uric acid and 5,6-diaminouracil derivatives as novel agents against free radical processes: synthesis and in vitro activity.

Fraisse L, Verlhac JB, Roche B, Rascle MC, Rabion A, Seris JL.

J Med Chem. 1993 May 14;36(10):1465-73. Erratum in: J Med Chem 1993 Sep 17;36(19):2832.

PMID:
8496914
23.

Assay of phenylethanolamine N-methyltransferase activity using high-performance liquid chromatography with ultraviolet absorbance detection.

Beaudouin C, Haurat G, Fraisse L, Souppe J, Renaud B.

J Chromatogr. 1993 Mar 5;613(1):51-8.

PMID:
8458902
24.
25.

Flux-dependent increase in the stoichiometry of charge translocation by mitochondrial ATPase/ATP synthase induced by almitrine.

Rigoulet M, Fraisse L, Ouhabi R, Guérin B, Fontaine E, Leverve X.

Biochim Biophys Acta. 1990 Jul 17;1018(1):91-7.

PMID:
2165421

Supplemental Content

Loading ...
Support Center